PUBLIC DISCLOSURE & CLARIFICATION

BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.

CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.

Cyclocytidine dipalmitate liposomes

Inquiry

Cat. No.: X26-05-ZQ920

Cyclocytidine dipalmitate liposomes

Name: Cyclocytidine dipalmitate liposomes
SKU: X26-05-ZQ920

Inquiry

Synonym: Cyclocytidine dipalmitate LPs; Dipalmitoyl cyclocytidine liposomes; Cyclocytidine dipalmitate-loaded liposomes

Product Size

100 mg; 250 mg; 500 mg; 1 g; 5 g

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

This product features cyclocytidine dipalmitate liposomes (CC-DP LPs) containing a synthetic lipophilic nucleoside derivative. The formulation utilizes the dipalmitate ester prodrug of cyclocytidine, which incorporates seamlessly into the saturated phospholipid bilayer matrix. The presence of the long-chain fatty acid esters increases the membrane hydrophobic thickness and physical rigidity. The resulting spherical vesicles exhibit reduced permeability to small water-soluble ions.

Source

Custom synthesis

Functional Group

Cyclocytidine dipalmitate

Form

Solid or powder

Purity

≥95%

Impurities

No visible impurities to the naked eye.

Identity

HPLC/MS/NMR

Publications

Publications (0)

Publications

×

Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.